Tarsus Pharmaceuticals, Inc. Stock Performance

Open $78.89	Prev. Close $79.00	Circuit Range N/A
Day Range $77.47 - $78.89	Year Range $51.80 - $91.44	Volume 4,976
Average Traded $78.14

Tarsus Pharmaceuticals, Inc. Share Price Today

As of 18 September 2026, Tarsus Pharmaceuticals, Inc.'s share price is $78.66. The stock opened at $78.89, compared to its previous close of $79.00. During today's trading session, Tarsus Pharmaceuticals, Inc.'s share price traded between $77.47 and $78.89, with an average price of $78.18. Over the past 52 weeks, the stock has recorded a high of $91.44 and a low of $51.80. In terms of performance, Tarsus Pharmaceuticals, Inc.'s share price has risen by 12.26% over the last six months and is up 32.27% on a year-on-year basis.

Tarsus Pharmaceuticals, Inc. Share Price Chart

$77.47$78.89

Tarsus Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap $3.29B	PE Ratio (TTM) -49.47	Dividend Yield N/A
EPS (TTM) $-1.59	Revenue (TTM) $451.36M	Return On Equity (TTM) -19.34%
Profit Margin -14.72%	Debt to Equity 0.40	Quarterly Earnings Growth YoY 46.26%

Tarsus Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

Particulars	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025
Revenue	N/A	$40.81M	$48.12M	$78.33M	$102.66M	$118.70M
Net Profit	-$35.73M	-$33.29M	-$23.42M	-$25.12M	-$20.34M	-$12.59M
Net Profit Margin	N/A	-81.57%	-48.67%	-32.07%	-19.81%	-10.60%
Income Change	N/A	6.83%	29.65%	-7.26%	19.03%	38.13%

Tarsus Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars	2021	2022	2023	2024	2025
Revenue	$57.03M	$25.82M	$17.45M	$182.95M	$451.36M
Net Profit	-$13.83M	-$62.09M	-$135.89M	-$115.55M	-$66.42M
Net Profit Margin	-24.25%	-240.51%	-778.89%	-63.16%	-14.72%
Income Change	N/A	-349.06%	-118.86%	14.97%	42.52%

About Tarsus Pharmaceuticals, Inc.

Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States. The company's lead product candidate is XDEMVY, a novel therapeutic for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. It is also developing TP-04 for the treatment of Ocular Rosacea; TP-05 for potential Lyme disease prophylaxis; and community malaria reduction. In addition, the company develops lotilaner active pharmaceutical ingredient (API) to address diseases in human medicine, including eye care and infectious disease prevention. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.

Tarsus Pharmaceuticals, Inc. Historical Returns

Month	Open	Close	Change %
Sep 2026	$74.11	$78.58	+9.22%
Aug 2026	$60.15	$71.95	+22.02%
Jul 2026	$65.04	$58.97	-6.18%
Jun 2026	$59.26	$62.85	+5.92%
May 2026	$62.60	$59.34	-6.84%
Apr 2026	$70.71	$63.70	-9.09%
Mar 2026	$74.11	$70.07	-7.20%
Feb 2026	$65.19	$75.51	+16.98%
Jan 2026	$81.56	$64.55	-21.29%
Dec 2025	$80.00	$82.02	+2.24%
Nov 2025	$69.25	$80.22	+16.41%
Oct 2025	$58.95	$68.91	+15.87%

TARS Share Price FAQs

What is Tarsus Pharmaceuticals, Inc. share price today?

Tarsus Pharmaceuticals, Inc. share price today is $78.66 as on September 18, 2026 at 8:43 pm IST.

What is the 52 week high and 52 week low of Tarsus Pharmaceuticals, Inc. stock?

The 52 week high of Tarsus Pharmaceuticals, Inc. stock is $91.44, while the 52 week low is $51.80 as of 18 Sep '26.

What is TARS's market capitalisation today?

TARS market capitalisation is $3.29B as of September 18, 2026, at 8:44 pm IST.

What is TARS's net income for the last quarter?

TARS's net income for the last quarter is -0.01B USD.

What is the 5 year returns of TARS?

The 5 year returns of TARS is 265.01% as on 18 Sep '26.

What is the high & low stock price of TARS today?

TARS stock price hit a high of $78.89 and low of $77.47 as of 18 Sep '26.

Can I buy TARS shares in India?

Yes. You can buy TARS in India by opening an international trading account.